Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Por Kukulska Aleksandra, Krajewska Jolanta, Gawkowska-Suwińska Marzena, Puch Zbigniew, Paliczka-Cieslik Ewa, Roskosz Jozef, Handkiewicz-Junak Daria, Jarzab Michał, Gubała Elzbieta, Jarzab Barbara
Publicado em 2010-11-01

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Por Kukulska, Aleksandra, Krajewska, Jolanta, Gawkowska-Suwińska, Marzena, Puch, Zbigniew, Paliczka-Cieslik, Ewa, Roskosz, Jozef, Handkiewicz-Junak, Daria, Jarzab, Michał, Gubała, Elzbieta, Jarzab, Barbara
Publicado em 2010

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patie...

Por Handkiewicz-Junak, Daria, Roskosz, Jozef, Hasse-Lazar, Kornelia, Szpak-Ulczok, Sylwia, Puch, Zbigniew, Kukulska, Aleksandra, Olczyk, Tomasz, Piela, Andrzej, Paliczka-Cieslik, Ewa, Jarzab, Barbara
Publicado em 2009

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Por Krajewska, Jolanta, Jarzab, Michal, Kukulska, Aleksandra, Czarniecka, Agnieszka, Roskosz, Jozef, Puch, Zbigniew, Wygoda, Zbigniew, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Krol, Aleksandra, Handkiewicz-Junak, Daria, Jarzab, Barbara
Publicado no Nucl Med Mol Imaging (2019)

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma

Por Kukulska, Aleksandra, Krajewska, Jolanta, Kolosza, Zofia, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Pawlaczek, Agnieszka, Puch, Zbigniew, Ficek, Kornelia, Lisik, Teresa, Sygula, Dorota, Wygoda, Zbigniew, Roskosz, Jozef, Wydmanski, Jerzy, Jarzab, Barbara
Publicado no Endocr Connect (2019)

SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility

Por He, Huiling, Bronisz, Agnieszka, Liyanarachchi, Sandya, Nagy, Rebecca, Li, Wei, Huang, Yungui, Akagi, Keiko, Saji, Motoyasu, Kula, Dorota, Wojcicka, Anna, Sebastian, Nikhil, Wen, Bernard, Puch, Zbigniew, Kalemba, Michal, Stachlewska, Elzbieta, Czetwertynska, Malgorzata, Dlugosinska, Joanna, Dymecka, Kinga, Ploski, Rafal, Krawczyk, Marek, Morrison, Patrick J., Ringel, Matthew D., Kloos, Richard T., Jazdzewski, Krystian, Symer, David E., Vieland, Veronica J., Ostrowski, Michael, Jarząb, Barbara, de la Chapelle, Albert
Publicado em 2013